A small animal peripheral challenge model of yellow fever using interferon-receptor deficient mice and the 17D-204 vaccine strain
- 1 May 2012
- Vol. 30 (21), 3180-3187
- https://doi.org/10.1016/j.vaccine.2012.03.003
Abstract
No abstract availableKeywords
Funding Information
- NIH/NIAID (U54AI-065357)
- Rocky Mountain Regional Center of Excellence for Biodefense and Emerging Infectious Disease Research
- Centers for Disease Control and Prevention
This publication has 31 references indexed in Scilit:
- Inhibition of Dengue Virus Infections in Cell Cultures and in AG129 Mice by a Small Interfering RNA Targeting a Highly Conserved SequenceJournal of Virology, 2011
- A Mouse Model for Studying Viscerotropic Disease Caused by Yellow Fever Virus InfectionPLoS Pathogens, 2009
- Development of a Human-Murine Chimeric Immunoglobulin M Antibody for Use in the Serological Detection of Human Flavivirus AntibodiesClinical and Vaccine Immunology, 2009
- Molecular targets for flavivirus drug discoveryAntiviral Research, 2008
- E Protein Domain III Determinants of Yellow Fever Virus 17D Vaccine Strain Enhance Binding to Glycosaminoglycans, Impede Virus Spread, and Attenuate VirulenceJournal of Virology, 2008
- Closing the door on flaviviruses: Entry as a target for antiviral drug designAntiviral Research, 2008
- Murine Model for Dengue Virus-Induced Lethal Disease with IncreasedVascular PermeabilityJournal of Virology, 2006
- Yellow fever vaccine: An updated assessment of advanced age as a risk factor for serious adverse eventsVaccine, 2005
- Advanced Age a Risk Factor for Illness Temporally Associated with Yellow Fever VaccinationEmerging Infectious Diseases, 2001
- Lethal 17D Yellow Fever Encephalitis in Mice. I. Passive Protection by Monoclonal Antibodies to the Envelope Proteins of 17D Yellow Fever and Dengue 2 VirusesJournal of General Virology, 1986